Comparison of glycemic control among diabetics using the defferent insulin pen needles.
- Conditions
- Type 1 and 2 diabetes
- Registration Number
- JPRN-UMIN000004642
- Lead Sponsor
- Tokyo Medical University The 3rd Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
1)Pregnancy or possibility of pregnancy. 2)Lactating women 3)Serious neurological diseases 4)Physical conditions which unable subjects to carry out the study procedures (e.g., Incapability to inject by themselves). 5)Thyroid deficiencies and/or nephrotic syndrome. 6)Patients who are currently enrolled in another clinical study 7)Patients who have already discussed details with employees of BD Japan or enrolled study subjects regarding the Investigation. 8)Patients for whom Principle Investigator or Investigators consider that their enrollment could expose them to any risk. 9)Patients who can confuse the interpretation of investigation results or who have done. 10)Employees of pharmaceutical or medical device companies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Average variation rates between glycated albumin level after one-month use of BD Microfine plus 32G x 4mm and that after one-month use of Novo Pen needle 32G x 6mm.
- Secondary Outcome Measures
Name Time Method